POInTprotocol.full
1Ziegler A-G, et al. BMJ Open 2019;9:e028578. doi:10.1136/bmjopen-2018-028578 Open access Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD- POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol Anette-Gabriele Ziegler,1,2 Peter Achenbach,1,2 Reinhard Berner,3 Kristina Casteels,4,5 Thoma
https://www.gppad.lu.se/sites/gppad.lu.se/files/2025-05/POInTprotocol.full_.pdf - 2026-04-15
